Showing 181-190 of 648 results for "".
New American Academy of Neurology Disease-Modifying Treatment Guidelines: Impact on Clinical Practice
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/new-american-academy-of-neurology-disease-modifying-treatment-guidelines-impact-on-clinical-practice/30208/Key concepts and checklists provide a framework for optimal decision making with patients.Biomarkers in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/imaging-testing/biomarkers-in-multiple-sclerosis/30195/Biomarkers have resulted from breakthrough treatments and, in turn, provide targets for more breakthroughs.Sleep & Neurodegenerative Disease
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/sleep--neurodegenerative-disease/30108/Sleep problems are common and treatable in neurodegenerative disorders, and may also be a treatable risk factor and early biomarker.Integrative Care for Patients With Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/integrative-care-for-patients-with-multiple-sclerosis/30217/What is integrative care, and why should clinicians care about it?Clinical Use of Alzheimer Disease Biomarkers: Legal, Ethical, and Social Considerations
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/clinical-use-of-alzheimer-disease-biomarkers-legal-ethical-and-social-considerations/32141/Legal, ethical, and social considerations are emerging along with the clinical implementation of Alzheimer disease biomarkers.Parkinson Disease ICD-10-CM Coding
https://practicalneurology.com/diseases-diagnoses/movement-disorders/parkinson-disease-iicd-10-cmi-coding/31825/Current ICD-10-CM coding does not adequately reflect the complexity of Parkinson disease after motor fluctuations and dyskinesia emerge.Neurologic Complications of Tick-Borne Diseases
https://practicalneurology.com/diseases-diagnoses/imaging-testing/neurologic-complications-of-tick-borne-diseases/32152/As the incidence of tick-borne diseases increases, neurologists must recognize and treat their neurologic manifestations.EMG and Nerve Conduction Studies in Clinical Practice
https://practicalneurology.com/diseases-diagnoses/neuromuscular/emg-and-nerve-conduction-studies-in-clinical-practice/30863/Electrodiagnostic studies are helpful in evaluating weakness, muscle wasting, and sensory symptoms. More specific questions may allow more detailed and directed conclusions.Movement Disorders Moment: Use of 3D Motion Capture for Kinematic Analysis in Movement Disorders
https://practicalneurology.com/diseases-diagnoses/movement-disorders/movement-disorders-moment-use-of-3d-motion-capture-for-kinematic-analysis-in-movement-disorders/32077/The emerging technology, 3D motion capture, can improve diagnosis, clinical decision-making, and clinical trial precision in movement disorders.Movement Disorders Moment: Atypical Parkinsonisms
https://practicalneurology.com/diseases-diagnoses/movement-disorders/movement-disorders-moment-atypical-parkinsonisms/31608/Pearls from the September 2019 International Congress of Parkinson’s Disease and Movement Disorders